NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

DXCM

Dexcom Inc

Apr 17 • 04:00PM ET

68.57

Dollar change -0.16
Percentage change -0.23	%

Healthcare • Medical Devices • USA • NASD

Peers: ABT MDT TNDM PODD BSX SENS GMED ZBH SYK TDOC

| Held by: VTI VOO VO QQQ SPY IVV VUG VOT XLV IWP

Scroll to Statements

Index	NDX, S&P 500	P/E	48.13	EPS (ttm)	1.42	Insider Own	1.40%	Shs Outstand	390.70M	Perf Week	1.89%
Market Cap	26.89B	Forward P/E	27.71	EPS next Y	2.47	Insider Trans	-2.52%	Shs Float	386.62M	Perf Month	-6.55%
Income	576.20M	PEG	2.13	EPS next Q	0.33	Inst Own	92.66%	Short Float	2.85%	Perf Quarter	-19.18%
Sales	4.03B	P/S	6.67	EPS this Y	23.32%	Inst Trans	-1.05%	Short Ratio	2.60	Perf Half Y	2.19%
Book/sh	5.38	P/B	12.74	EPS next Y	22.35%	ROA	9.04%	Short Interest	11.01M	Perf Year	-49.77%
Cash/sh	6.58	P/C	10.42	EPS next 5Y	22.57%	ROE	27.63%	52W Range	57.52 - 139.24	Perf YTD	-11.83%
Dividend Est.	-	P/FCF	42.63	EPS past 5Y	39.06%	ROI	16.64%	52W High	-50.75%	Beta	1.39
Dividend TTM	-	Quick Ratio	1.28	Sales past 5Y	22.46%	Gross Margin	60.46%	52W Low	19.21%	ATR (14)	3.34
Dividend Ex-Date	-	Current Ratio	1.47	EPS Y/Y TTM	4.24%	Oper. Margin	14.88%	RSI (14)	47.32	Volatility	3.27% 4.87%
Employees	10300	Debt/Eq	1.23	Sales Y/Y TTM	11.34%	Profit Margin	14.29%	Recom	1.48	Target Price	100.96
Option/Short	Yes / Yes	LT Debt/Eq	0.65	EPS Q/Q	-39.07%	Payout	0.00%	Rel Volume	0.87	Prev Close	68.73
Sales Surprise	0.39%	EPS Surprise	-6.09%	Sales Q/Q	7.64%	Earnings	May 01 AMC	Avg Volume	4.23M	Price	68.57
SMA20	1.29%	SMA50	-10.12%	SMA200	-12.27%	Trades		Volume	3,702,730	Change	-0.23%

Date	Action	Analyst	Rating Change	Price Target Change
Apr-10-25	Initiated	Mizuho	Outperform	$85
Feb-03-25	Upgrade	Redburn Atlantic	Neutral → Buy	$85 → $115
Jan-16-25	Upgrade	Robert W. Baird	Neutral → Outperform	$86 → $104
Jul-26-24	Downgrade	Robert W. Baird	Outperform → Neutral	$161 → $80
Jul-26-24	Downgrade	JP Morgan	Overweight → Neutral	$145 → $75
May-30-24	Initiated	Redburn Atlantic	Neutral	$130
Mar-12-24	Initiated	RBC Capital Mkts	Outperform	$165
May-30-23	Resumed	Morgan Stanley	Equal-Weight	$131
Apr-17-23	Upgrade	Raymond James	Outperform → Strong Buy	$127 → $138
Mar-29-23	Initiated	UBS	Buy	$142
Jan-26-23	Initiated	Wolfe Research	Outperform	$121
Oct-18-22	Initiated	Barclays	Equal Weight	$103
Oct-12-22	Initiated	Jefferies	Buy	$125
Jul-15-22	Initiated	Bernstein	Outperform	$105
Mar-02-22	Resumed	BofA Securities	Buy	$500
Feb-03-22	Upgrade	BTIG Research	Neutral → Buy	$535
Jan-19-22	Upgrade	Wells Fargo	Equal Weight → Overweight	$575
Jan-07-22	Upgrade	Guggenheim	Neutral → Buy	$580
Oct-18-21	Downgrade	Guggenheim	Buy → Neutral
Jul-21-21	Resumed	Cowen	Outperform	$540 → $525

Show Previous Ratings

Apr-16-25 10:19AM	Tariffs, Trump, and Turmoil (Motley Fool)
Apr-14-25 03:00PM	Tap Into the Silver Economy Boom With These Aging Demographics Stocks (Zacks)
Apr-11-25 01:01PM	DexCom Shares May Rise as G7 15-Day CGM System Gets FDA Clearance (Zacks)
12:08PM	Analyst Report: DexCom, Inc. (Morningstar Research)
12:05PM	Prada to acquire Versace, CarMax reports mixed Q4 results: Morning Buzz (TipRanks)
01:37PM	Loading…
Apr-10-25 01:37PM	FDA Approves New DexCom Diabetes Device (Investopedia)
01:28PM	FDA Approves Dexcom's 15-Day Wearable Glucose Management System. Company Plans US Launch (Benzinga)
11:34AM	DexCom Stock Rises as Glucose Monitoring System Gets FDA Clearance (Barrons.com)
10:15AM	2 Growth Stocks to Buy in the Tariff-Fueled Market Correction (Motley Fool)
10:07AM	Dexcom nets FDA clearance for 15-day CGM (MedTech Dive)
09:34AM	Dexcom Surges After FDA Clears Its Next-Generation Diabetes Device (Investor's Business Daily)
08:30AM	Dexcom G7 15 Day Receives FDA Clearance: the Longest Lasting Wearable and Most Accurate CGM System (Business Wire)
Apr-04-25 08:06AM	Here's Why You Should Retain DexCom Stock in Your Portfolio for Now (Zacks)
Apr-03-25 02:22PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.30%
08:30AM	Dexcom Schedules First Quarter 2025 Earnings Release and Conference Call for May 1, 2025 at 4:30 p.m. Eastern Time. (Business Wire)
08:59AM	Loading…
Apr-01-25 08:59AM	DexCom (DXCM) Slid on Poor Execution and GLP-1 Drug Disruption Concerns (Insider Monkey)
08:00AM	Government of Saskatchewan Expands Public Coverage for Dexcom Continuous Glucose Monitoring Systems (Business Wire)
Mar-31-25 09:30AM	DXCM Inks Deal With Nanowear to Boost CGM Application Beyond Diabetes (Zacks)
Mar-28-25 01:38PM	Baird Q4 2024 Mid Cap Growth Strategy Commentary (Seeking Alpha)
Mar-27-25 11:40AM	Dexcom rejects claims of unauthorized device changes in FDA warning letter (MedTech Dive)
09:04AM	DXCM Stock Falls as FDA Warnings Raise Concern for 15-Day G7 Approval (Zacks)
Mar-26-25 07:31AM	Dexcoms FDA warning letter reveals unauthorized changes to sensors (MedTech Dive)
07:17AM	DXCM Stock Gains Following New Data on Upcoming G7 CGM Sensor (Zacks)
Mar-25-25 04:05PM	Dexcom Appoints Jon Coleman as Chief Commercial Officer (Business Wire)
07:38AM	Dexcom COO on 15-day glucose sensor, Type 2 coverage (MedTech Dive)
Mar-24-25 05:10AM	DexCom (DXCM): 3 Reasons We Love This Stock (StockStory)
Mar-19-25 10:02AM	Nasdaq Sell-Off: 2 Brilliant Stocks to Buy No Matter What the Market Does Next (Fool)
04:00AM	Dexcom Report Unveiled at ATTD 2025 Reveals HCPs Favour Tech Over Medication for Future of Type 2 Care (Business Wire)
Mar-18-25 01:43PM	DexCom, Inc. (DXCM): Among the Best Diabetes Stocks to Buy According to Billionaires (Insider Monkey)
Mar-11-25 02:15PM	Analysts say Dexcoms FDA warning unlikely to impact 2025 revenue (Medical Device Network)
05:07AM	Loading…
05:07AM	Patient Monitoring Stocks Q4 Results: Benchmarking ResMed (NYSE:RMD) (StockStory)
Mar-10-25 07:31PM	Analyst Report: DexCom, Inc. (Morningstar Research) -9.15%
04:29PM	Why Dexcom Is On A Six-Day Losing Spree But This Analyst Isn't Worried (Investor's Business Daily)
11:53AM	Top Stock Movers Now: Tesla, DexCom, Strategy, and More (Investopedia)
10:15AM	DexCom Stock Drops as Diabetes Devices Maker Gets FDA Warning Letter (Investopedia)
08:30AM	Dexcom Appoints Rene Gal to Board of Directors (Business Wire)
02:57AM	Dexcom receives warning letter based on FDA inspections of 2 plants (MedTech Dive)
Mar-08-25 08:17AM	Is DexCom, Inc. (DXCM) the Best Growth Stock Under $100 to Buy Now? (Insider Monkey)
Mar-07-25 05:51PM	Dexcom receives FDA warning letter for two U.S. manufacturing facilities (Reuters) -9.15%
05:33PM	DexCom Gets FDA Warning Letter After Inspections of Facilities (The Wall Street Journal)
Mar-01-25 06:14PM	3 Growth Stocks to Buy and Hold Forever (Motley Fool)
Feb-27-25 08:30AM	Dexcom Announces Upcoming Conference Presentation (Business Wire)
04:05AM	Reflecting On Patient Monitoring Stocks Q4 Earnings: DexCom (NASDAQ:DXCM) (StockStory)
Feb-26-25 04:32AM	Got $200? 2 Healthcare Stocks to Buy and Hold Forever (Motley Fool)
Feb-25-25 07:30AM	Seasoned Biopharmaceutical Industry Executives Teri Lawver and Jerry Durso Appointed to Altimmune Board of Directors (GlobeNewswire)
Feb-18-25 03:10PM	Is DexCom, Inc. (DXCM) the Best IoT Stock to Buy According to Analysts? (Insider Monkey)
Feb-14-25 03:04PM	Analyst Cautiously Optimistic On DexCom As Competitive Pressures Loom (Benzinga) +5.92%
09:05AM	Dexcom Stock Makes A Recovery After Its Fourth-Quarter Fumble (Investor's Business Daily)
02:20AM	DexCom Inc (DXCM) Q4 2024 Earnings Call Highlights: Revenue Growth Amid Margin Challenges (GuruFocus.com)
12:08AM	Analyst Report: DexCom, Inc. (Morningstar Research)
Feb-13-25 09:45PM	DexCom (DXCM) Q4 2024 Earnings Call Transcript (Motley Fool)
05:56PM	Informatica CEO on earnings, top trading themes: Asking for a Trend (Yahoo Finance Video)
05:30PM	Here's What Key Metrics Tell Us About DexCom (DXCM) Q4 Earnings (Zacks)
05:22PM	GameStop, Twilio, DexCom: After-hours movers (Yahoo Finance Video)
05:15PM	DexCom (DXCM) Misses Q4 Earnings Estimates (Zacks)
05:10PM	DexComs (NASDAQ:DXCM) Q4: Beats On Revenue (StockStory)
04:41PM	Dexcom Fumbles In The Fourth Quarter As Profit Misses Forecasts By A Nickel (Investor's Business Daily)
04:19PM	DexCom: Q4 Earnings Snapshot (Associated Press Finance)
04:12PM	Dexcom Tumbles As Fourth-Quarter Profit Lags Expectations (Investor's Business Daily)
04:02PM	Dexcom Reports Fourth Quarter and Fiscal Year 2024 Financial Results (Business Wire)
Feb-12-25 09:13AM	Is DexCom, Inc. (DXCM) the Best Medical Device Stock to Buy? (Insider Monkey)
08:07AM	DexCom (DXCM) To Report Earnings Tomorrow: Here Is What To Expect (StockStory)
Feb-10-25 09:16AM	Countdown to DexCom (DXCM) Q4 Earnings: A Look at Estimates Beyond Revenue and EPS (Zacks)
Feb-06-25 10:01AM	DexCom (DXCM) Q4 Earnings Preview: What's in the Cards? (Zacks)
09:30AM	Should You Buy DexCom Stock Before Feb. 13? (Motley Fool)
Feb-04-25 08:15AM	Heres Why Aristotle Atlantic Focus Growth Strategy Sold its Stake in DexCom (DXCM) (Insider Monkey)
Feb-03-25 09:15AM	Prediction: This Top Growth Stock Will Outperform the Market in the Next Decade (Motley Fool)
08:45AM	Got $2,000? 2 Top Growth Stocks to Buy and Hold for Years (Motley Fool)
Jan-30-25 08:30AM	Dexcom Schedules Fourth Quarter and Fiscal Year 2024 Earnings Release and Conference Call for February 13, 2025 at 4:30 p.m. Eastern Time. (Business Wire)
Jan-20-25 12:55PM	How Dexcom and URA are unifying two distinct market sectors (Medical Device Network)
Jan-16-25 07:28PM	Analyst Report: DexCom, Inc. (Morningstar Research) +5.52%
06:46PM	Why DexCom, Inc. (DXCM) Is Skyrocketing (Insider Monkey)
05:21PM	S&P 500 Gains and Losses Today: UnitedHealth Stock Ails as Results Fall Short (Investopedia)
12:14PM	Baird raises DexCom stock to outperform, target to $104 (Investing.com)
05:22AM	2 Healthcare Stocks to Buy Hand Over Fist in January (Motley Fool)
Jan-15-25 05:50AM	Dexcom CEO talks Stelo sensor launch, OTC strategy (MedTech Dive)
Jan-14-25 07:38AM	JP Morgan 2025: Dexcom shares up 5% after 2025 outlook forecasts $4.6bn in revenue (Medical Device Network)
Jan-13-25 07:30AM	Dexcom Reports Preliminary, Unaudited Results for the Fourth Quarter and Fiscal Year 2024 and Initial 2025 Outlook (Business Wire)
Jan-09-25 08:37AM	Health Tracking Is Moving To Smart Rings From Watches. Oura Leads Market. (Investor's Business Daily)
Jan-08-25 04:35PM	Why Is Jim Cramer Mystified by DexCom, Inc. (DXCM)s Earnings Miss and Competitive Challenges? (Insider Monkey)
08:30AM	3 Beaten-Down Stocks That May Be Due for Big Comebacks in 2025 (Motley Fool)
Jan-07-25 08:30AM	Dexcom to Present at 43rd Annual J.P. Morgan Healthcare Conference (Business Wire)
Jan-04-25 07:45AM	These Were the 5 Worst-Performing Stocks in the Nasdaq-100 in 2024 (Motley Fool)
Jan-02-25 06:26AM	Abbott, Dexcom settle glucose monitor patent lawsuits (MedTech Dive)
Jan-01-25 09:37AM	The 5 worst performing stocks on the Nasdaq 100 in 2024 (TheStreet)
Dec-25-24 10:15AM	Abbott, DexCom settlement not a complete surprise, says Wells Fargo (TipRanks)
05:30AM	DexCom, Abbott agree to settle patent litigation (TipRanks)
Dec-23-24 04:56PM	DexCom, Abbott Agree to Settlement in Patent Litigation (The Wall Street Journal)
06:28AM	DexCom (DXCM) Soars 5.6%: Is Further Upside Left in the Stock? (Zacks)
Dec-21-24 06:45AM	1 Reason to Sell DexCom Stock, and 1 Reason to Buy (Motley Fool)
Dec-20-24 04:48PM	S&P 500 Gains and Losses Today: Index Rebounds After Encouraging Inflation Data (Investopedia) +5.57%
Dec-18-24 11:52AM	Dexcom implements GenAI into glucose biosensor devices (Medical Device Network)
07:07AM	AI-Driven Glucose Biosensing: Dexcoms (DXCM) Path To A Comeback (Insider Monkey)
06:13AM	Dexcom adds generative AI to over-the-counter CGMs (MedTech Dive)
Dec-17-24 09:00AM	Dexcom Launches the First Generative AI Platform in Glucose Biosensing (Business Wire)
08:00AM	Alberta Government Lifts Age Restrictions on Continuous Glucose Monitors (CGM) and Eligible Albertans With Type 1 or Type 2 Diabetes Can Now Access Dexcom G7 CGM (Business Wire)
06:45AM	Is Dexcom, Inc. (DXCM) the Best Weight Loss Stock to Buy Now According to Hedge Funds? (Insider Monkey)
Dec-10-24 11:21AM	Dexcom shares up as Diabetes Association updates guidelines (Investing.com)
Dec-02-24 09:12AM	3 Reasons to Buy DexCom Stock Like There's No Tomorrow (Motley Fool)
Nov-28-24 07:45AM	2 Excellent Healthcare Stocks to Hold Through the Next Decade (Motley Fool)

DexCom, Inc. is a medical device company, which engages in the design, development, and commercialization of glucose monitoring systems for ambulatory use by people with diabetes. Its products include Dexcom G6, Dexcom G7, Dexcom Stelo, Dexcom Share, Dexcom Real-Time API, and Dexcom ONE. The company was founded by John F. Burd on May 13, 1999 and is headquartered in San Diego, CA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
Heller Bridgette P	Director	Mar 17 '25	Sale	70.33	352	24,756	22,997	Mar 19 05:02 PM
Heller Bridgette P	Director	Mar 17 '25	Proposed Sale	70.33	352	24,756		Mar 17 09:40 AM
Leach Jacob Steven	EVP, Chief Operating Officer	Mar 12 '25	Sale	70.38	14,076	990,670	313,497	Mar 14 05:25 PM
Brown Michael Jon	EVP, Chief Legal Officer	Mar 12 '25	Sale	70.38	13,000	914,941	105,602	Mar 14 05:25 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 12 '25	Sale	70.38	12,001	844,632	123,481	Mar 14 05:25 PM
Stern Sadie	EVP, Chief HR Officer	Mar 12 '25	Sale	70.38	11,176	786,568	115,805	Mar 14 05:25 PM
SAYER KEVIN R	Chairman, CEO & President	Mar 12 '25	Sale	70.38	32,498	2,287,212	372,029	Mar 14 05:24 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Mar 10 '25	Sale	73.83	7,000	516,830	135,482	Mar 11 07:17 PM
JEREME SYLVAIN	Officer	Mar 10 '25	Proposed Sale	73.83	7,000	516,830		Mar 10 04:03 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Jan 29 '25	Sale	86.91	2,090	181,650	83,526	Jan 30 06:44 PM
Dolan Matthew Vincent	EVP, Strategy & Corporate Dev	Jan 29 '25	Sale	86.91	1,183	102,820	42,044	Jan 30 06:44 PM
Stern Sadie	EVP, Chief HR Officer	Jan 29 '25	Sale	86.91	2,093	181,911	74,261	Jan 30 06:44 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Jan 29 '25	Sale	86.91	2,634	228,932	268,644	Jan 30 06:44 PM
SAYER KEVIN R	Chairman, CEO & President	Jan 29 '25	Sale	86.91	33,359	2,899,367	319,037	Jan 30 06:43 PM
Stern Sadie	EVP, Chief HR Officer	Dec 16 '24	Sale	76.87	424	32,593	70,768	Dec 17 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Dec 16 '24	Sale	76.87	744	57,191	80,030	Dec 17 04:15 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Dec 16 '24	Sale	76.87	744	57,191	264,171	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Sale	76.87	1,000	76,870	23,349	Dec 17 04:15 PM
Heller Bridgette P	Director	Dec 16 '24	Proposed Sale	76.87	1,000	76,870		Dec 16 11:56 AM
Stern Sadie	EVP, Chief HR Officer	Nov 20 '24	Sale	74.73	4,259	318,275	71,192	Nov 22 04:15 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Nov 15 '24	Sale	75.51	3,500	264,285	80,774	Nov 18 04:12 PM
JEREME SYLVAIN	Officer	Nov 15 '24	Proposed Sale	75.51	3,500	264,285		Nov 15 04:04 PM
Heller Bridgette P	Director	Sep 16 '24	Sale	70.00	1,000	70,000	24,349	Sep 17 04:17 PM
Heller Bridgette P	Director	Sep 16 '24	Proposed Sale	70.00	1,000	70,000		Sep 16 09:53 AM
Stern Sadie	EVP, Chief HR Officer	Sep 09 '24	Sale	69.15	426	29,458	75,451	Sep 11 07:05 PM
Sylvain Jereme M	EVP, Chief Financal Officer	Sep 09 '24	Sale	69.15	746	51,586	84,274	Sep 11 07:05 PM
Leach Jacob Steven	EVP, Chief Operating Officer	Sep 09 '24	Sale	69.15	746	51,586	264,915	Sep 11 07:05 PM
Brown Michael Jon	EVP, Chief Legal Officer	Aug 30 '24	Sale	70.00	686	48,020	65,636	Sep 03 04:22 PM
MICHAEL BROWN	Officer	Aug 30 '24	Proposed Sale	70.00	686	48,020		Aug 30 04:32 PM
Brown Michael Jon	EVP, Chief Legal Officer	Jul 31 '24	Sale	69.55	652	45,347	66,249	Aug 01 07:23 PM
MICHAEL BROWN	Officer	Jul 31 '24	Proposed Sale	69.55	652	45,347		Jul 31 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Jun 28 '24	Sale	114.29	659	75,317	66,901	Jun 28 05:34 PM
FOLETTA MARK G	Director	Jun 18 '24	Sale	116.79	3,306	386,122	56,398	Jun 20 04:50 PM
FOLETTA MARK G	Director	Jun 17 '24	Sale	117.26	2,694	315,907	59,704	Jun 20 04:50 PM
Heller Bridgette P	Director	Jun 14 '24	Sale	113.55	1,000	113,550	25,349	Jun 18 07:16 PM
Sylvain Jereme M	EVP Chief Financial Officer	Jun 10 '24	Sale	115.05	745	85,713	84,948	Jun 11 06:39 PM
Stern Sadie	EVP Chief HR Officer	Jun 10 '24	Sale	115.05	427	49,127	75,877	Jun 11 06:39 PM
Leach Jacob Steven	EVP Chief Operating Officer	Jun 10 '24	Sale	115.05	745	85,713	265,577	Jun 11 06:38 PM
Brown Michael Jon	EVP Chief Legal Officer	May 31 '24	Sale	119.24	652	77,744	67,560	May 31 05:27 PM
Dolan Matthew Vincent	EVP Strategy and Corporate Dev	May 15 '24	Sale	126.58	2,423	306,703	40,075	May 16 04:04 PM
Brown Michael Jon	EVP Chief Legal Officer	Apr 30 '24	Sale	126.25	629	79,411	68,212	May 02 05:07 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

DXCM

Dexcom Inc

Upgrade your FINVIZ experience